FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age

13.08.25 15:50 Uhr

Werte in diesem Artikel
Aktien

23,21 EUR 0,14 EUR 0,59%

Indizes

PKT PKT

18.081,7 PKT 100,0 PKT 0,56%

3.342,0 PKT -3,5 PKT -0,11%

6.715,8 PKT 0,4 PKT 0,01%

The U.S. Food and Drug Administration (FDA) may not renew the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine for children under the age of five, the company said. The possible move would pull the only available coronavirus vaccine for young children from the market. "We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season," a spokesperson for Pfizer said in a statement to Fox News Digital."It is important to note that these deliberations are not related to the safety and efficacy of the vaccine which continues to demonstrate a favorable profile," it said.  RFK JR SCRAPS VACCINE COMMITTEE MEMBERS IN EFFORT TO RESTORE 'PUBLIC TRUST'Children aged 6 months to 4 years "[w]ho are moderately or severely immunocompromised" may take a Moderna shot, according to the Centers for Disease Control and Prevention's (CDC) child immunization schedule.Otherwise, different recommendations are made for the 5-11 and 12-17-year age ranges. "The COVID-19 pandemic ended with the expiration of the federal public health emergency in May 2023," an HHS spokesperson said in a statement to Fox News Digital, adding that the department does "[n]ot comment on potential, future regulatory changes.""Unless officially announced by HHS, discussion about future agency action should be regarded as pure speculation," it said. CDC REMOVES COVID VACCINE RECOMMENDATION FOR HEALTHY CHILDREN AND PREGNANT WOMENBack in May, Health and Human Services (HHS) Director Robert F. Kennedy Jr. sent out a post on X that read, "[T]he COVID vaccine for healthy children and healthy pregnant women has been removed from @CDCgov recommended immunization schedule." "[W]e are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Kennedy said in June. "The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies."The executive director of the American Public Health Association, Georges Benjamin, told The Guardian the number of those vaccinated is low, but the move would still have an impact. "It certainly would create a hole in the availability of vaccines," Benjamin said. "And to do it this late in the season – I think clearly it's inappropriate."CLICK HERE TO GET THE FOX NEWS APPFox News Digital's Cameron Arcand contributed to this report. Weiter zum vollständigen Artikel bei FOX Business

In eigener Sache

Übrigens: Pfizer und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf AG&E

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf AG&E

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: FOX Business

Nachrichten zu Pfizer Inc.

Wer­bung

Analysen zu Pfizer Inc.

DatumRatingAnalyst
02.10.2025Pfizer BuyJefferies & Company Inc.
01.10.2025Pfizer BuyJefferies & Company Inc.
30.09.2025Pfizer NeutralJP Morgan Chase & Co.
24.09.2025Pfizer BuyJefferies & Company Inc.
22.09.2025Pfizer NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
02.10.2025Pfizer BuyJefferies & Company Inc.
01.10.2025Pfizer BuyJefferies & Company Inc.
24.09.2025Pfizer BuyJefferies & Company Inc.
06.08.2025Pfizer KaufenDZ BANK
21.05.2025Pfizer BuyJefferies & Company Inc.
DatumRatingAnalyst
30.09.2025Pfizer NeutralJP Morgan Chase & Co.
22.09.2025Pfizer NeutralJP Morgan Chase & Co.
17.09.2025Pfizer HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
05.08.2025Pfizer NeutralUBS AG
05.08.2025Pfizer NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
03.05.2018Pfizer VerkaufenDZ BANK
16.05.2017Pfizer SellCitigroup Corp.
27.11.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)
28.08.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)
10.01.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Pfizer Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen